The Role of Mammalian Target of Rapamycin (mTOR) Inhibitors in the Treatment of Solid Tumors

Publisher： Bentham Science Publishers

E-ISSN： 1875-6301|4|3|227-234

ISSN： 1573-3947

Source： Current Cancer Therapy Reviews, Vol.4, Iss.3, 2008-08, pp. : 227-234

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Innovations therapy: mammalian target of rapamycin (mTOR) inhibitors for the treatment of neuroendocrine tumors

By Capdevila Jaume   Salazar Ramón   Halperín Irene   Abad Albert   Yao James  

Cancer and Metastasis Reviews, Vol. 30, Iss. 1, 2011-03 ,pp. : 27-34

Springer Publishing Company

Access to resources Recommend Favorite

The emerging role of mammalian target of rapamycin inhibitors in the treatment of sarcomas

By Vemulapalli Sushma  

Targeted Oncology, Vol. 6, Iss. 1, 2011-03 ,pp. : 29-39

Springer Publishing Company

Access to resources Recommend Favorite

Future directions of mammalian target of rapamycin (mTOR) inhibitor therapy in renal cell carcinoma

By Pal Sumanta  

Targeted Oncology, Vol. 6, Iss. 1, 2011-03 ,pp. : 5-16

Springer Publishing Company

Access to resources Recommend Favorite

Updates of mTOR Inhibitors

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 7, 2010-09 ,pp. : 571-581

Bentham Science Publishers

Access to resources Recommend Favorite

Role of mTOR in Hematological Malignancies

By  

Current Cancer Therapy Reviews, Vol. 4, Iss. 3, 2008-08 ,pp. : 211-218

Bentham Science Publishers

Access to resources Recommend Favorite